IL6 and diabetic kidney disease: According to studies, obesity‐related insulin resistance will lead to an increase in cytokine IL‐6, which itself will lead to the occurrence of inflammation and increase albuminuria [45], and so inhibition of cytokines and thus inflammation may be a therapeutic target to improve and prevent diabetic nephropathy [46].